Latest Headlines

  1. Almac Doubles Global 2-8°C Cold Room Capacity In Response To Increasing Biologics Demand
    10/1/2014

    Almac recently announced a significant investment to more than double the existing capacity of their 2-8°C clinical supply labelling cold room facilities in the Group’s European and USA based facilities.

  2. Weekly Pharma Manufacturing News Roundup — September 30, 2014
    9/30/2014

    A Pharmaceutical Processing article discusses the factors that are driving the future of high toxic pharmaceutical manufacturing. In particular, the article highlights a risk-based approach for manufacturing pharmaceutical products for pharma and CMOs planning to expand or add high-potency API manufacturing capacity to their offerings. The article breaks down the risk-based approach into three categories: Hazard characterization, OEL Setting, ADE setting, and Hazard Bands.

  3. FDA News Roundup: MedImmune, Celgene, Lundbeck, And More
    9/29/2014

    AstraZeneca’s R&D arm, MedImmune, received fast track designation from the FDA for its investigational monoclonal antibody (mAb) MEDI3902 indicated to prevent Pseudomonas aeruginosa (P. aeruginosa)-caused pneumonia.

  4. FDA News Roundup: Eli Lilly, Tekmira, Regeneron, AstraZeneca, And More
    9/25/2014

    In the face of the Ebola threat, the FDA has granted Tekmira Pharmaceuticals permission via an “Expanded Access” or a “Compassionate Use” program to distribute its investigational Ebola treatment, TKM-Ebola, to people with confirmed or suspected infection.

  5. Pharmaceutical Packaging Innovation Advances Quality, Speed & Efficiency
    9/25/2014

    As pharmaceutical manufacturers aim to combat counterfeiters and speed time to market, new package printing technologies are making it easier for them to overcome these hurdles without sacrificing the bottom line.

  6. Weekly Pharma Manufacturing News Roundup — September 23, 2014
    9/23/2014

    Three experts in part one of CPhl’s second annual report have voiced their expectations for the industry and have come out in favor of several “radical changes” that will help spur innovation and reduce pharma manufacturing costs

  7. UPS Survey: Time To Act On Untapped Opportunities In Healthcare Industry
    9/23/2014

    An environment of increasing risks, complex regulations and continuing cost pressures is impeding healthcare executives from moving quickly to seize untapped industry opportunities, according to the 7th annual UPS "Pain in the (Supply) Chain" survey. Globally, healthcare executives are planning for strategic partnerships and technology investment to mitigate risks and capitalize on growth opportunities.

  8. FDA News Roundup: Baxter, Mylan, Shire, And More
    9/22/2014

    NPS Pharmaceuticals received a nod of approval from an FDA Advisory Committee for its Hypoparathyroidism disorder drug, Natpara.

  9. Warehouse Monitoring: Medical/Surgical Supply Distributor Improves Efficiency And Compliance
    9/22/2014

    Owens & Minor, Mechanicsville, VA, is a leading U.S. supplier of medical and surgical products to hospitals, integrated healthcare systems, alternate care locations, and the federal government.

  10. Dyzle To Demonstrate Integrated Monitoring, Tracking And Analytics Platform Complete With Mobile App To Enable Full Cold Chain Visibility Worldwide And Deliver Proof Of Product Integrity
    9/22/2014

    Dyzle BV, the global leader in measuring and analyzing business process data for the cold chain in real-time, will demonstrate a complete technology platform solution to enable full cold chain visibility worldwide and provide proof of product integrity at the 12th Annual Cold Chain GDP & Temperature Management Logistics Global Forum in Boston, MA, USA next week (1-2 October 2014).

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.